Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
Acerta Pharma BV
Janssen Pharmaceutical K.K.
University College, London
BeiGene
BeiGene
University of Rochester
Mayo Clinic
University of Nebraska
TG Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
Brown University
Karyopharm Therapeutics Inc
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Dana-Farber Cancer Institute
Hackensack Meridian Health
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Cancer Research UK
ADC Therapeutics S.A.
Barbara Ann Karmanos Cancer Institute
Pharmacyclics LLC.
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
Mayo Clinic
Eli Lilly and Company
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
Pharmacyclics LLC.
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
University of Arizona
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
Mayo Clinic
University of Chicago
Gilead Sciences
Fred Hutchinson Cancer Center
Mayo Clinic
Yale University